Teva Pharmaceutical Industries (LTS:0LER) Institutional Ownership: 22.55% (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0LER Teva Pharmaceutical Industries Ltd LTS:0LER
45 GF Score
Price $35.60
GF Value $20.76
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Teva Pharmaceutical Industries Institutional Ownership?

Teva Pharmaceutical Industries LTS:0LER +6.27% 45 Institutional Ownership is 22.55% as of Aug. 02, 2026. GuruFocus rates LTS:0LER with a GF Score™ of 45/100 and a GF Value™ of $20.76 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Teva Pharmaceutical Industries's institutional ownership is 22.55%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Teva Pharmaceutical Industries's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Teva Pharmaceutical Industries's Float Percentage Of Total Shares Outstanding is 0.00%.

Teva Pharmaceutical Industries Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Teva Pharmaceutical Industries's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teva Pharmaceutical Industries Institutional Ownership Chart

Teva Pharmaceutical Industries Historical Data

The historical data trend for Teva Pharmaceutical Industries can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 17.34 17.44 18.13 19.01 19.17 19.44 21.27 21.45 21.61 22.55
LTS:0LER
45GF Score
Teva Pharmaceutical Industries Ltd LTS:0LER
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teva Pharmaceutical Industries Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 22.55% mean?
Teva Pharmaceutical Industries (LTS:0LER) has a Institutional Ownership of 22.55% as of Aug. 02, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Teva Pharmaceutical Industries and its competitors.
Is Teva Pharmaceutical Industries' Institutional Ownership too high?
Teva Pharmaceutical Industries' current Institutional Ownership is 22.55%. Overall, Teva Pharmaceutical Industries has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Teva Pharmaceutical Industries' Institutional Ownership compare to ZTS and UTHR?
Teva Pharmaceutical Industries' Institutional Ownership of 22.55% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Teva Pharmaceutical Industries and its competitors. Teva Pharmaceutical Industries's current Institutional Ownership is 22.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teva Pharmaceutical Industries stock overvalued right now?
Based on GuruFocus' analysis, Teva Pharmaceutical Industries (LTS:0LER) is currently considered Significantly Overvalued. The stock's GF Value™ is $20.76, compared to a current price of $35.60 — trading 71.5% above its estimated fair value. The current Institutional Ownership is 22.55%. Teva Pharmaceutical Industries' overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Teva Pharmaceutical Industries (LTS:0LER), the current Institutional Ownership is 22.55% as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teva Pharmaceutical Industries (LTS:0LER) Overvalued in 2026?

Based on GuruFocus' analysis, Teva Pharmaceutical Industries stock appears to be overvalued. The current stock price of $35.60 is trading 71.5% above its estimated GF Value™ of $20.76. GuruFocus considers Teva Pharmaceutical Industries to be Significantly Overvalued.

Key valuation signals for LTS:0LER:

  • Institutional Ownership: 22.55%
  • GF Value™: $20.76 vs. price of $35.60 (71.5% above fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the LTS:0LER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teva Pharmaceutical Industries Business Description

Address 124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
45GF Score

Get the complete analysis for LTS:0LER

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$35.60
Price
$20.76
GF Value